Literature DB >> 29622668

Utility of Electronic Medical Record Alerts to Prevent Drug Nephrotoxicity.

Melissa Martin1, F Perry Wilson2,3.   

Abstract

Nephrotoxin-induced AKI is an iatrogenic form of AKI that can be potentially avoided or ameliorated by prompt recognition and appropriate prescriber actions. Drug-targeted alerts, either for patients at risk of AKI or patients with existing AKI, may lead to more appropriate drug dosing and management and improved clinical outcomes. However, alerts of this type are complicated to create, have a high potential for error and off-target effects, and may be difficult to evaluate. Although many studies have shown that these alerts can reduce the rate of inappropriate prescribing, few studies have examined the utility of such alerts in terms of patient benefit. In this review, we examine the current state of the literature in this area, identify key technical challenges, and suggest methods of evaluation for drug-targeted AKI alerts.
Copyright © 2019 by the American Society of Nephrology.

Entities:  

Keywords:  Acute Kidney Injury; Alert; Clinical Decision Support; Drug Prescriptions; Electronic Health Records; Humans; Iatrogenic Disease; Inappropriate Prescribing; acute renal failure; drug nephrotoxicity; nephrotoxicity; pharmacokinetics

Mesh:

Year:  2018        PMID: 29622668      PMCID: PMC6364537          DOI: 10.2215/CJN.13841217

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  43 in total

1.  Development of a Multicenter Ward-Based AKI Prediction Model.

Authors:  Jay L Koyner; Richa Adhikari; Dana P Edelson; Matthew M Churpek
Journal:  Clin J Am Soc Nephrol       Date:  2016-09-15       Impact factor: 8.237

2.  Comparison of methods for estimating glomerular filtration rate in critically ill patients with acute kidney injury.

Authors:  Josée Bouchard; Etienne Macedo; Sharon Soroko; Glenn M Chertow; Jonathan Himmelfarb; Talat Alp Ikizler; Emil P Paganini; Ravindra L Mehta
Journal:  Nephrol Dial Transplant       Date:  2009-08-13       Impact factor: 5.992

3.  Guided medication dosing for inpatients with renal insufficiency.

Authors:  G M Chertow; J Lee; G J Kuperman; E Burdick; J Horsky; D L Seger; R Lee; A Mekala; J Song; A L Komaroff; D W Bates
Journal:  JAMA       Date:  2001-12-12       Impact factor: 56.272

4.  Reducing excessive medication administration in hospitalized adults with renal dysfunction.

Authors:  Ira S Nash; Mary Rojas; Paul Hebert; Stephen R Marrone; Claudia Colgan; Lori A Fisher; Gina Caliendo; Mark R Chassin
Journal:  Am J Med Qual       Date:  2005 Mar-Apr       Impact factor: 1.852

5.  Adverse drug events during AKI and its recovery.

Authors:  Zachary L Cox; Allison B McCoy; Michael E Matheny; Gautam Bhave; Neeraja B Peterson; Edward D Siew; Julia Lewis; Ioana Danciu; Aihua Bian; Ayumi Shintani; T Alp Ikizler; Erin B Neal; Josh F Peterson
Journal:  Clin J Am Soc Nephrol       Date:  2013-03-28       Impact factor: 8.237

6.  Iatrogenic renal disease.

Authors:  M Davidman; P Olson; J Kohen; T Leither; C Kjellstrand
Journal:  Arch Intern Med       Date:  1991-09

7.  Acute kidney injury: outcomes and quality of care.

Authors:  E Aitken; C Carruthers; L Gall; L Kerr; C Geddes; D Kingsmore
Journal:  QJM       Date:  2013-01-22

8.  False-Positive Rate of AKI Using Consensus Creatinine-Based Criteria.

Authors:  Jennie Lin; Hilda Fernandez; Michael G S Shashaty; Dan Negoianu; Jeffrey M Testani; Jeffrey S Berns; Chirag R Parikh; F Perry Wilson
Journal:  Clin J Am Soc Nephrol       Date:  2015-09-03       Impact factor: 8.237

9.  Septic acute kidney injury in critically ill patients: clinical characteristics and outcomes.

Authors:  Sean M Bagshaw; Shigehiko Uchino; Rinaldo Bellomo; Hiroshi Morimatsu; Stanislao Morgera; Miet Schetz; Ian Tan; Catherine Bouman; Ettiene Macedo; Noel Gibney; Ashita Tolwani; Heleen M Oudemans-van Straaten; Claudio Ronco; John A Kellum
Journal:  Clin J Am Soc Nephrol       Date:  2007-03-21       Impact factor: 8.237

10.  Drug management in acute kidney disease - Report of the Acute Disease Quality Initiative XVI meeting.

Authors:  Marlies Ostermann; Lakhmir S Chawla; Lui G Forni; Sandra L Kane-Gill; John A Kellum; Jay Koyner; Patrick T Murray; Claudio Ronco; Stuart L Goldstein
Journal:  Br J Clin Pharmacol       Date:  2017-12-01       Impact factor: 4.335

View more
  7 in total

1.  Redundant combinations of antianaerobic antimicrobials: impact of pharmacist-based prospective audit and feedback and prescription characteristics.

Authors:  Moonsuk Kim; Hyung-Sook Kim; Young Joo Song; Eunsook Lee; Kyoung-Ho Song; Pyoeng Gyun Choe; Wan Beom Park; Ji Hwan Bang; Eu Suk Kim; Sang-Won Park; Nam Joong Kim; Myoung-Don Oh; Hong Bin Kim
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-09-03       Impact factor: 3.267

2.  AKI!Now Initiative: Recommendations for Awareness, Recognition, and Management of AKI.

Authors:  Kathleen D Liu; Stuart L Goldstein; Anitha Vijayan; Chirag R Parikh; Kianoush Kashani; Mark D Okusa; Anupam Agarwal; Jorge Cerdá
Journal:  Clin J Am Soc Nephrol       Date:  2020-04-21       Impact factor: 8.237

3.  Alerting to acute kidney injury - Challenges, benefits, and strategies.

Authors:  Josko Ivica; Geetha Sanmugalingham; Rajeevan Selvaratnam
Journal:  Pract Lab Med       Date:  2022-04-02

Review 4.  For Whom the Bell Tolls: Acute Kidney Injury and Electronic Alerts for the Pediatric Nephrologist.

Authors:  Elizabeth D Nguyen; Shina Menon
Journal:  Front Pediatr       Date:  2021-04-12       Impact factor: 3.418

5.  DNA demethylase Tet2 suppresses cisplatin-induced acute kidney injury.

Authors:  Yinwu Bao; Mengqiu Bai; Huanhuan Zhu; Yuan Yuan; Ying Wang; Yunjing Zhang; Junni Wang; Xishao Xie; Xi Yao; Jianhua Mao; Xianghui Fu; Jianghua Chen; Yi Yang; Weiqiang Lin
Journal:  Cell Death Discov       Date:  2021-06-17

6.  Teasing out Artificial Intelligence in Medicine: An Ethical Critique of Artificial Intelligence and Machine Learning in Medicine.

Authors:  Mark Henderson Arnold
Journal:  J Bioeth Inq       Date:  2021-01-07       Impact factor: 2.216

7.  Design, development, and deployment of an indication- and kidney function-based decision support tool to optimize treatment and reduce medication dosing errors.

Authors:  Jamie S Hirsch; Rajdeep Brar; Christopher Forrer; Christine Sung; Richard Roycroft; Pradeep Seelamneni; Hemala Dabir; Ambareen Naseer; Pranisha Gautam-Goyal; Kevin R Bock; Michael I Oppenheim
Journal:  JAMIA Open       Date:  2021-06-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.